Marjon van Slegtenhorst

Dr. Marjon van Slegtenhorst is a researcher in the Department of Clinical Genetics at Erasmus MC, Erasmus Medical Center, the Netherlands. She is actively contributing to research in the fields of clinical genetics, inherited cardiomyopathies, and neurodevelopmental disorders, with a particular focus on hypertrophic cardiomyopathy, genotype-negative disease expression, and exome sequencing applications.

Her research interests span hypertrophic cardiomyopathy, RBM20-associated cardiomyopathy, genotype-negative myocardial disease, exome sequencing, neurodevelopmental disorders, and genotyping. She investigates how genetic and non-genetic factors influence disease expression, especially in cardiovascular conditions, and contributes to improving diagnostic and screening protocols.

The trends in her recent publications highlight a strong focus on clinical genetics and cardiology, particularly in understanding disease mechanisms in hypertrophic cardiomyopathy, evaluating quality of life in patients, and analyzing cohort data for rare genetic forms of heart disease. Her work integrates molecular genetics with clinical outcomes, emphasizing translational research.

She has no listed scientific awards in the provided text.

Dr. van Slegtenhorst collaborates extensively within Erasmus MC and on multicenter studies, contributing to significant research outputs. While no grants or student advisement details are mentioned, her co-authorship on numerous peer-reviewed articles, including original research and reviews, underscores her active role in academic medicine and research teams focused on genetic cardiovascular diseases.

She is part of a robust research network in clinical genetics and contributes to advancing knowledge in both cardiac and neurodevelopmental genetic disorders through high-impact publications and collaborative science.